Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 202.90

-1.7%

12:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (27963)	2/7/1999 12:28:00 PM
From: Machaon	Read Replies (1) of 32384

<< Other post-approval commitments include a trial to determine the objective response rate in patients whose malignant cells do not express the CD25 component of the IL-2 receptor. >> Henry, ONTAK is manufactured to search and destroy based on the CD25 component. Would you have any idea why the FDA would want this additional trial based on "not expressing CD25"? TIA, Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next